Xarelto vs Crestor
A side-by-side look at two cardiovascular medications advertised on TV. Informational only — not medical advice.
| CA Xarelto | CA Crestor | |
|---|---|---|
| Generic name | rivaroxaban | rosuvastatin |
| Drug class | Factor Xa Inhibitor | Statin |
| Treats | Blood clots, atrial fibrillation | High cholesterol, cardiovascular prevention |
| Category | Cardiovascular | Cardiovascular |
| Manufacturer | Bayer/Janssen | AstraZeneca |
| Year approved | 2012 | 2003 |
| FDA warning | Black box warning | No boxed warning |
| Est. TV ad spend | $28M | $7M |
| Common side effects | Serious bleeding risk, Bruising, Prolonged bleeding, Dizziness | Muscle pain, Headache, Liver problems, Weakness |
Frequently asked questions
Is Xarelto or Crestor better?
Neither is universally "better." Xarelto (rivaroxaban) and Crestor (rosuvastatin) are both used for cardiovascular, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Xarelto and Crestor?
Xarelto is a Factor Xa Inhibitor made by Bayer/Janssen, while Crestor is a Statin made by AstraZeneca. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Xarelto has the larger estimated TV advertising budget of the two.